| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4192791
[patent_doc_number] => 06043232
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs'
[patent_app_type] => 1
[patent_app_number] => 9/235802
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5652
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043232.pdf
[firstpage_image] =>[orig_patent_app_number] => 235802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235802 | Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs | Jan 21, 1999 | Issued |
Array
(
[id] => 4099190
[patent_doc_number] => 06048858
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Compositions and methods to prevent toxicity induced by nonsteroidal antiflammatory drugs'
[patent_app_type] => 1
[patent_app_number] => 9/235803
[patent_app_country] => US
[patent_app_date] => 1999-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17990
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048858.pdf
[firstpage_image] =>[orig_patent_app_number] => 235803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/235803 | Compositions and methods to prevent toxicity induced by nonsteroidal antiflammatory drugs | Jan 21, 1999 | Issued |
Array
(
[id] => 4408983
[patent_doc_number] => 06239137
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity'
[patent_app_type] => 1
[patent_app_number] => 9/231147
[patent_app_country] => US
[patent_app_date] => 1999-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 7290
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239137.pdf
[firstpage_image] =>[orig_patent_app_number] => 231147
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/231147 | Salts of aminoimidazole carboxamide and 5 amino or substituted amino 1,2,3-triazole, induce apoptosis, inhibit DNA synthesis and control cyclooxygenase activity | Jan 14, 1999 | Issued |
| 09/226832 | 3,4-DIHYDRO-2H-BENZO(1,4)OXAZINE DERIVATIVES | Jan 6, 1999 | Pending |
| 09/226831 | 3,4-DIHYDRO-2H-BENZO{1,4}OXAZINYL-METHYL)-{3-(1H-INDOL-3-YL)-ALKYL}- AMINES | Jan 6, 1999 | Pending |
Array
(
[id] => 4116219
[patent_doc_number] => 06046234
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225701
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13634
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046234.pdf
[firstpage_image] =>[orig_patent_app_number] => 225701
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225701 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4101548
[patent_doc_number] => 06066645
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225693
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13688
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066645.pdf
[firstpage_image] =>[orig_patent_app_number] => 225693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225693 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4101894
[patent_doc_number] => 06066668
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225694
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13685
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066668.pdf
[firstpage_image] =>[orig_patent_app_number] => 225694
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225694 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4220190
[patent_doc_number] => 06040304
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225695
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13633
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040304.pdf
[firstpage_image] =>[orig_patent_app_number] => 225695
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225695 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4114994
[patent_doc_number] => 06046159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225697
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13632
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046159.pdf
[firstpage_image] =>[orig_patent_app_number] => 225697
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225697 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4099046
[patent_doc_number] => 06048849
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225700
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13632
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048849.pdf
[firstpage_image] =>[orig_patent_app_number] => 225700
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225700 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4109958
[patent_doc_number] => 06057361
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225702
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13629
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/057/06057361.pdf
[firstpage_image] =>[orig_patent_app_number] => 225702
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225702 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4193088
[patent_doc_number] => 06043249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/226384
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13634
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043249.pdf
[firstpage_image] =>[orig_patent_app_number] => 226384
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/226384 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4220042
[patent_doc_number] => 06040294
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/226760
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040294.pdf
[firstpage_image] =>[orig_patent_app_number] => 226760
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/226760 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 5, 1999 | Issued |
Array
(
[id] => 4220311
[patent_doc_number] => 06040312
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Formulations and methods of reducing toxicity of antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 9/225957
[patent_app_country] => US
[patent_app_date] => 1999-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13633
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040312.pdf
[firstpage_image] =>[orig_patent_app_number] => 225957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/225957 | Formulations and methods of reducing toxicity of antineoplastic agents | Jan 4, 1999 | Issued |
Array
(
[id] => 4160732
[patent_doc_number] => 06114569
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-05
[patent_title] => 'Efficient synthesis of A 1,4-dihydro-2H-3,1-benzoxazin-2-one'
[patent_app_type] => 1
[patent_app_number] => 9/224923
[patent_app_country] => US
[patent_app_date] => 1999-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5823
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/114/06114569.pdf
[firstpage_image] =>[orig_patent_app_number] => 224923
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/224923 | Efficient synthesis of A 1,4-dihydro-2H-3,1-benzoxazin-2-one | Jan 3, 1999 | Issued |
Array
(
[id] => 1595501
[patent_doc_number] => 06384079
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging'
[patent_app_type] => B1
[patent_app_number] => 09/224949
[patent_app_country] => US
[patent_app_date] => 1999-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8617
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384079.pdf
[firstpage_image] =>[orig_patent_app_number] => 09224949
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/224949 | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | Jan 3, 1999 | Issued |
Array
(
[id] => 4358916
[patent_doc_number] => 06174889
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/214270
[patent_app_country] => US
[patent_app_date] => 1998-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23967
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 887
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174889.pdf
[firstpage_image] =>[orig_patent_app_number] => 214270
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/214270 | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors | Dec 30, 1998 | Issued |
Array
(
[id] => 4410125
[patent_doc_number] => 06172260
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Preparation of high dye-yield couplers and intermediates useful therein'
[patent_app_type] => 1
[patent_app_number] => 9/224476
[patent_app_country] => US
[patent_app_date] => 1998-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9348
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172260.pdf
[firstpage_image] =>[orig_patent_app_number] => 224476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/224476 | Preparation of high dye-yield couplers and intermediates useful therein | Dec 30, 1998 | Issued |
Array
(
[id] => 4160012
[patent_doc_number] => 06156884
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-05
[patent_title] => 'Bifunctional boronic compound complexing reagents and complexes'
[patent_app_type] => 1
[patent_app_number] => 9/222468
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23856
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/156/06156884.pdf
[firstpage_image] =>[orig_patent_app_number] => 222468
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222468 | Bifunctional boronic compound complexing reagents and complexes | Dec 28, 1998 | Issued |
